{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T08:50:43Z","timestamp":1690966243479},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,1]]},"DOI":"10.2146\/ajhp170534","type":"journal-article","created":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T10:25:18Z","timestamp":1529922318000},"page":"958-961","source":"Crossref","is-referenced-by-count":4,"title":["Treatment of<i>Aspergillus fumigatus<\/i>infection with posaconazole delayed-release tablets"],"prefix":"10.1093","volume":"75","author":[{"given":"Suzanne","family":"Shearin","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Carolinas Medical Center, Charlotte, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Bell","sequence":"additional","affiliation":[{"name":"Duke Children\u2019s Hospital and Health Center, Durham, NC"},{"name":"College of Pharmacy and Health Sciences, Campbell University, Durham, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041105255794500_b1-0750958","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1378\/chest.130.1.222","article-title":"Aspergillus bronchitis in cystic fibrosis","volume":"130","author":"Shoseyov","year":"2006","journal-title":"Chest"},{"key":"key\n\t\t\t\t2019041105255794500_b2-0750958","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/508774","article-title":"Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial","volume":"44","author":"Walsh","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019041105255794500_b3-0750958","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.pcl.2005.02.009","article-title":"Antifungal agents in children","volume":"52","author":"Steinbach","year":"2005","journal-title":"Pediatr Clin North Am"},{"key":"key\n\t\t\t\t2019041105255794500_b4-0750958","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1128\/AAC.01034-08","article-title":"Pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers","volume":"53","author":"Krishna","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019041105255794500_b5-0750958","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12281-014-0185-y","article-title":"Update on posaconazole pharmacokinetics: comparison of old and new formulations","volume":"8","author":"Percival","year":"2014","journal-title":"Curr Fungal Infect Rep"},{"key":"key\n\t\t\t\t2019041105255794500_b6-0750958","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/phar.1533","article-title":"Review of the new delayed-release oral tablet and intravenous dosage forms of posaconazole","volume":"35","author":"Guarascio","year":"2015","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t2019041105255794500_b7-0750958","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/jac\/dks268","article-title":"A new solid oral tablet formulation of posaconazole: a randomized clinical trial to investigate rising single- and multiple-dose pharmacokinetics and safety in healthy volunteers","volume":"67","author":"Krishna","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019041105255794500_b8-0750958","article-title":"Effect of concomitant medications affecting gastric pH and motility on posaconazole tablet pharmacokinetics","author":"Kraft"},{"key":"key\n\t\t\t\t2019041105255794500_b9-0750958","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/clpt.2010.64","article-title":"Exposure-response of posaconazole used for prophylaxis against invasive fungal infections: evaluating the need to adjust doses based on drug concentrations in plasma","volume":"88","author":"Jang","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t2019041105255794500_b10-0750958","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1128\/AAC.02739-15","article-title":"Visual hallucinations associated with high posaconazole concentrations in serum","volume":"60","author":"Parkes","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019041105255794500_b11-0750958","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jac\/dkx362","article-title":"Persistent CNS toxicity in a patient receiving posaconazole tablets after discontinuation of voriconazole due to supratherapeutic serum levels","volume":"73","author":"Foolad","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019041105255794500_b12-0750958","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1345\/aph.1R775","article-title":"Posaconazole therapeutic drug monitoring in pediatric patients and young adults with cancer","volume":"47","author":"Hoffman","year":"2013","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t2019041105255794500_b13-0750958","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00007691-199906000-00004","article-title":"Population pharmacokinetics of aminoglycoside antibiotics in patient with cystic fibrosis","volume":"21","author":"Campbell","year":"1999","journal-title":"Ther Drug Monitor"},{"key":"key\n\t\t\t\t2019041105255794500_b14-0750958","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.2165\/00003088-200645110-00004","article-title":"Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients","volume":"45","author":"Hennig","year":"2006","journal-title":"Clin Pharmacokinet"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/75\/13\/958\/28346307\/ajhp0958.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T23:04:13Z","timestamp":1571526253000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/75\/13\/958\/5101993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,1]]},"references-count":14,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp170534","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,7,1]]},"published":{"date-parts":[[2018,7,1]]}}}